Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InspireMD Inc NSPR

Healthcare Medical Devices
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet... see more

Recent & Breaking News (NDAQ:NSPR)

InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke

GlobeNewswire 3 days ago

InspireMD Announces Appointment of Michael Lawless as Chief Financial Officer

GlobeNewswire 12 days ago

InspireMD Reports First Quarter 2025 Financial Results

GlobeNewswire May 9, 2025

InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference

GlobeNewswire April 30, 2025

InspireMD to Announce First Quarter 2025 Financial Results

GlobeNewswire April 25, 2025

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire April 8, 2025

InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire March 26, 2025

InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire March 12, 2025

InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire February 26, 2025

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire February 25, 2025

InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime(TM) 80 cm Carotid Stent System for Use in TCAR procedures

GlobeNewswire February 13, 2025

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire February 4, 2025

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire January 21, 2025

InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025

GlobeNewswire December 12, 2024

InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR)

GlobeNewswire December 9, 2024

InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors

GlobeNewswire November 25, 2024

InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire November 12, 2024

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire November 8, 2024

InspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12th

GlobeNewswire November 4, 2024

InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent System

GlobeNewswire October 15, 2024